Erin E Krebs1, Kurt Kroenke2, Jingwei Wu3, Matthew J Bair2, Mary Ann Kozak4, Zhangsheng Yu5. 1. *Center for Chronic Disease Outcomes Research, Minneapolis VA Health Care System, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, USA. 2. Center for Health Information and Communication, Roudebush VA Medical Center, Department of Medicine, Regenstrief Institute, Inc., Indiana University School of Medicine, Indianapolis, Indiana, USA. 3. Department of Epidemiology and Biostatistics, College of Public Health, Temple University, Philadelphia, Pennsylvania, USA. 4. Department of Pharmacy Practice, Purdue University College of Pharmacy, Indianapolis, Indiana, USA. 5. Shanghai Jiaotong-Yale Joint Center of Biostatistics, Shanghai Jiaotong University, Shanghai, PR China.
Abstract
OBJECTIVE: To examine effects of pre-enrollment opioid use on outcomes of a 12-month collaborative pain care management trial. We hypothesized that participants with opioid use would have worse pain at baseline; use more health care services and analgesics; and have worse pain outcomes during the trial. DESIGN: Secondary analysis of randomized controlled trial data. SETTING: Veterans Affairs (VA) primary care. SUBJECTS:Patients age 18-65 years with chronic pain of at least moderate severity who were enrolled in a 12-month pragmatic trial of atelephone-based collaborative care intervention for chronic musculoskeletal pain. METHODS:Participants were categorized as opioid users (n = 84) or non-users (n = 166) at baseline and trial randomization was stratified by opioid use. We used logistic regression to examine cross-sectional associations with baseline opioid use and mixed-effect models for repeated measures to examine baseline opioid use as a predictor of Brief Pain Inventory (BPI) scores over 12 months. RESULTS: At baseline, 33.6% reported use of prescribed opioids. Baseline opioid users had higher baseline BPI scores and higher health-related disability than non-users. Baseline opioid users also had more outpatient visits (15.0 vs. 10.1; p = 0.001) and received more analgesics (p < 0.001) during the trial. In the final multivariable model examining effects of baseline opioid use on BPI over 12 months, opioid users and nonusers had a non-significant difference of 0.25 points (p = 0.098). In conclusion, although baseline opioid users had worse pain at baseline and used more health care during the study, response to the intervention was not significantly modified by pre-existing opioid therapy. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. 2016. This work is written by US Government employees and is in the public domain in the US.
RCT Entities:
OBJECTIVE: To examine effects of pre-enrollment opioid use on outcomes of a 12-month collaborative pain care management trial. We hypothesized that participants with opioid use would have worse pain at baseline; use more health care services and analgesics; and have worse pain outcomes during the trial. DESIGN: Secondary analysis of randomized controlled trial data. SETTING: Veterans Affairs (VA) primary care. SUBJECTS:Patients age 18-65 years with chronic pain of at least moderate severity who were enrolled in a 12-month pragmatic trial of a telephone-based collaborative care intervention for chronic musculoskeletal pain. METHODS:Participants were categorized as opioid users (n = 84) or non-users (n = 166) at baseline and trial randomization was stratified by opioid use. We used logistic regression to examine cross-sectional associations with baseline opioid use and mixed-effect models for repeated measures to examine baseline opioid use as a predictor of Brief Pain Inventory (BPI) scores over 12 months. RESULTS: At baseline, 33.6% reported use of prescribed opioids. Baseline opioid users had higher baseline BPI scores and higher health-related disability than non-users. Baseline opioid users also had more outpatient visits (15.0 vs. 10.1; p = 0.001) and received more analgesics (p < 0.001) during the trial. In the final multivariable model examining effects of baseline opioid use on BPI over 12 months, opioid users and nonusers had a non-significant difference of 0.25 points (p = 0.098). In conclusion, although baseline opioid users had worse pain at baseline and used more health care during the study, response to the intervention was not significantly modified by pre-existing opioid therapy. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. 2016. This work is written by US Government employees and is in the public domain in the US.
Entities:
Keywords:
Chronic Pain; Opioid Analgesics; Primary Care
Authors: Douglas Thornton; Nilanjana Dwibedi; Virginia Scott; Charles D Ponte; X I Tan; Douglas Ziedonis; Usha Sambamoorthi Journal: Am J Accountable Care Date: 2018-12-05